Strategic Active ETFs

Managed to pursue better outcomes

Healthcare

Strategic Equity

Alternatives

Explore our ETFs

What differentiates Tema?

Process

Bottom-up
fundamental
research-led
investment process

People

Experienced team
with sector
expertise

Product

Compelling
innovative
exposures

Positioning

Precise and
defined underlying
exposures

Learn more

Insights

view all insights

Why Reshoring Beats Nearshoring for Supply Chain and Manufacturing Security

By Chris Semenuk

How is Reshoring Affecting Your State?

By Chris Semenuk

Webinars

Latest Webinar

Trade, Tariffs and Reshoring

Nov 13th 01:00 PM ET

Meet our
investment team

Full profile

Full profile

Full profile

Chief Investment Officer
Yuri Khodjamirian, CFA

Yuri spent over a decade at Majedie Asset Management managing UK and Global portfolios. As co-manager of the Majedie UK Income Fund, he helped build the fund from start-up stage, raising several billion in assets. He later set up his own long-only fund and sits on the board of a private Scandinavian biotechnology company. He holds degrees in Economics from University of Cambridge and LSE (distinction), as well as a degree in Bioscience Enterprise from University of Cambridge. Yuri is a CFA charter holder.

TOLL

Full profile

Investment Partner
David K. Song, MD, PhD, CFA

David Song, Investment Partner, has led biotechnology and healthcare investment teams throughout his extensive 25-year career at Rockefeller Capital Management, Millennium and Balyasny. He studied Economics and Biochemistry at Yale, is a medical doctor and has a PhD in Applied Economics from Wharton.

HRTS

CANC

MNTL

Full profile

Investment Partner
Chris Semenuk

Chris is a global fund manager with more than 25 years of experience, 20 of which was spent managing a $5bn global equities fund at TIAA, a leading US based financial services company. Chris managed the fund since inception and raised several billion dollars in assets. Chris has a Bachelor's Degree in Economics from Union College in New York State.

RSHO

Full profile

Tema’s mission is to empower investors with unexplored and innovative solutions

Exchange-Traded Funds (ETFs)

A lineup that spans life sciences, core equity, and thematics.

Explore our ETFs

ETF Model
Portfolios

Differentiated, primarily open architecture solutions for the financial advisor needs of tomorrow.

GET in touch

Institutional
Solutions

Whether via separately managed accounts (SMAs), private funds, or other custom services, we have an experienced team ready to offer support.

Get in touch

Risk Information

Carefully consider the Fund’s investment objectives, risk factors, charges and expenses before investing. This and additional information can be found in the Fund’s prospectus or summary prospectus, which may be obtained by visiting www.temaetfs.com. Read the prospectus carefully before investing.

Diversification does not ensure profits or prevent losses.

Investing involves risk including possible loss of principal. The Funds may invest a significant portion of their assets in one or more sectors and thus will be more susceptible to the risks affecting those sectors than funds that have more diversified holdings across a number of sectors. There is no guarantee the adviser’s investment will be successful in identifying and investing in thematic trends.

The small- and mid-capitalization companies in which the Funds invest may be more vulnerable to adverse business or economic events than larger, more established companies, and may underperform other segments of the market or the equity market as a whole.

The Tema Alternative Investment Managers ETF prospectus was filed with the SEC on August 31st, 2022. Investing in the fund is not yet possible. Please see a copy of the prospectus linked here.

BEFORE INVESTING YOU SHOULD CAREFULLY CONSIDER THE FUND’S INVESTMENT OBJECTIVES, RISKS, CHARGES AND EXPENSES. THIS AND OTHER INFORMATION IS IN THE RESPECTIVE FUND PROSPECTUSES:

The Tema Electrification ETF prospectus was filed with the SEC on September 13th, 2024. Investing in the fund is not yet possible. Please see a copy of the prospectus linked here.

The Key Square Alternatives ETF prospectus was filed with the SEC on August 16th, 2024. Investing in the fund is not yet possible. Please see a copy of the prospectus linked here.

The Tema Endowment ETF prospectus was filed with the SEC on September 13th, 2024. Investing in the fund is not yet possible. Please see a copy of the prospectus linked here.

PLEASE READ THE PROSPECTUS CAREFULLY BEFORE YOU INVEST.

INFORMATION CONTAINED HEREIN IS SUBJECT TO COMPLETION OR AMENDMENT. A REGISTRATION STATEMENT RELATING TO THESE SECURITIES HAS BEEN FILED WITH THE SECURITIES AND EXCHANGE COMMISSION BUT HAS NOT YET BECOME EFFECTIVE. THESE SECURITIES MAY NOT BE SOLD NOR MAY OFFERS TO BUY BE ACCEPTED PRIOR TO THE TIME THE REGISTRATION STATEMENT BECOMES EFFECTIVE. THIS COMMUNICATION SHALL NOT CONSTITUTE AN OFFER TO BUY OR THE SOLICITATION OF AN OFFER TO BUY NOR SHALL THERE BE ANY SALE OF THESE SECURITIES IN ANY STATE IN WHICH SUCH OFFER, SOLICITATION OR SALE WOULD BE UNLAWFUL PRIOR TO REGISTRATION OR QUALIFICATION UNDER SECURITIES LAWS OF ANY SUCH STATE.

AN INDICATION OF INTEREST IN RESPONSE TO THIS ADVERTISEMENT WILL INVOLVE NO OBLIGATION OR COMMITMENT OF ANY KIND.

International and emerging market investing may involve risk of capital loss from unfavorable fluctuations in currency values, from differences in generally accepted accounting principles, or from economic or political instability in other nations. Frontier markets generally have less developed capital markets than traditional emerging market countries, and, consequently, the risks of investing in foreign securities are magnified in such countries.

Because the Funds evaluate ESG factors to assess and exclude certain investments for non-financial reasons, the Funds may forego some market opportunities available to funds that do not use these ESG factors.

Adviser: Tema Global Limited

Distributor: Foreside Fund Services, LLC.

The information on this website does not constitute investment advice or a recommendation of any products, strategies, or services. Investors should consult with a financial professional regarding their individual circumstances before making investment decisions. Tema Global Limited or its affiliates, nor Foreside Fund Services, LLC, or its affiliates accept any responsibility for loss arising from the use of the information contained herein.

Get in Touch

Strategic Active ETFs

Healthcare

HRTS

GLP-1, Obesity & Cardiometabolic ETF

CANC

Oncology ETF

MNTL

Neuroscience and Mental Health ETF

Strategic Equity

TOLL

Monopolies and Oligopolies ETF

RSHO

American Reshoring ETF

VOLT(coming soon)

Electrification ETF

Alternatives

AAUM(coming soon)

Alternative Investment Managers ETF

KALT(coming soon)

Key Square Alternatives ETF

YALE(coming soon)

Endowment ETF

What differentiates Tema?

Process

People

Product

Positioning

Subscribe to all Tema ETF updates

Insights

Why Reshoring Beats Nearshoring for Supply Chain and Manufacturing Security

How is Reshoring Affecting Your State?

Webinars

Trade, Tariffs and Reshoring

Nov 13th 01:00 PM ET

Meet our investment team

Chief Investment Officer Yuri Khodjamirian, CFA

Investment Partner David K. Song, MD, PhD, CFA

Investment Partner Chris Semenuk

Tema’s mission is to empower investors with unexplored and innovative solutions

Exchange-Traded Funds (ETFs)

ETF Model Portfolios

Institutional Solutions

Risk Information

Life Sciences

Strategic Equity

Alternatives

Funds Resources

GLP-1, Obesity &
Cardiometabolic ETF

Monopolies and
Oligopolies ETF

American
Reshoring ETF

VOLT_{(coming soon)}

AAUM_{(coming soon)}

KALT_{(coming soon)}

YALE_{(coming soon)}

Meet our
investment team

Chief Investment Officer
Yuri Khodjamirian, CFA

Investment Partner
David K. Song, MD, PhD, CFA

Investment Partner
Chris Semenuk

ETF Model
Portfolios

Institutional
Solutions